Infollion Research crossed ₹100 crore revenue milestone in FY26 with 30% annualized growth, but experienced significant volume softness in H2 (especially March with 25% lower per-day project flow). Management is aggressively investing in new geographies (US, MENA, EU) and new business line (Huxsa L&D platform) at the cost of ~₹2-2.5 crore in margins, while experiencing gross margin compression due to competitive pricing strategies and client development costs in newer markets.
Infollion crossed the ₹100 crore revenue threshold in FY26, representing approximately 30% annualized growth at volume level. EBITDA stood at ₹14.73 crore and PAT at ₹12.7 crore. The company generated over ₹10 crore cash flow from operations and over ₹8 crore in free cash flow, significantly strengthening the balance sheet. However, gross margins contracted from historical 45-46% levels, with management citing three factors: (1) aggressive pricing strategy to gain market share, (2) approximately ₹2-2.5 crore invested in new initiatives (Huxsa, international expansion, tech, sales teams) that don't yet generate meaningful revenue, and (3) H2 volume softness that cost approximately ₹1-1.5 crore in missed gross margin (estimated 500-1000 fewer calls than expected). Net margins compressed by 3-4%, with management indicating 1-2% is structural investment in new businesses. Employee expenses increased 25% while revenue grew 30%, with ₹2+ crore of incremental employee costs related to expansion initiatives. The company carries no debt, with ₹45 lakh in finance charges representing purely transaction fees on international payments.
Management struck a cautiously optimistic tone, acknowledging near-term weakness while emphasizing long-term structural positioning. CEO Gaurav Munjal was notably transparent about Q4/March challenges (25% decline in daily project flow) but attributed this to broader client slowdown rather than company-specific issues. He emphasized the company's deliberate choice to invest in growth over short-term margins, stating they could easily add 3% to net margins by halting expansion. Management is particularly bullish on their competitive moat in India, claiming to be equal to the next 2-3 competitors combined in market share and structurally positioned to offer the lowest margins while remaining highly profitable. The tone around new initiatives (Huxsa, US, MENA) was optimistic but appropriately cautious, with management acknowledging these are still nascent businesses. Leadership repeatedly emphasized they view the business as a derivative of India's consulting, private equity, and public market growth, and declined to provide quarterly guidance citing too many variables (war, AI impact, client conversions). Management also demonstrated strong capital allocation discipline, noting they've evaluated US acquisitions but found them either too expensive or lacking value, preferring organic build.
The company faces multiple significant headwinds. Volume growth decelerated sharply in H2 FY26, with March seeing 25% lower per-day project flow, indicating potential client budget constraints or market saturation. Management acknowledged most clients had "relatively flat" growth and noted consulting industry weakness as their revenues derive from strategy consulting, private equity, and public markets activity. Gross margin compression to below 45-46% historical levels raises concerns about pricing power and competitive intensity, though management frames this as voluntary aggression. The company is burning ₹2-2.5 crore annually on unproven new initiatives (Huxsa, international expansion) with uncertain payback timelines - management explicitly stated they cannot predict when these will become profitable even "in quarters." AI poses existential risk to the research business model, though management argues primary research is insulated versus secondary research. The US expansion remains subscale with high customer acquisition costs, requiring ~$8-10 crore (~$1M) revenue before justifying local hiring. Multi-vendor client environments create pricing pressure and require ongoing discounting to maintain stickiness. Employee productivity concerns emerged as headcount grew 35% (70 employees) while revenue grew 30%, with significant additions in unproven areas. The business operates in a structurally volatile environment where management admits inability to predict even near-term performance.
Revenue Outlook: Management declined to provide specific quarterly or annual guidance, citing too many variables (war impact, AI disruption, client conversion timing). Stated 5-year outlook remains positive as derivative of India economy. Expects international business growth to exceed core India growth. India business dependent on strategy consulting growth, PE investments, and public market performance.
Margin Outlook: Gross margins compressed below historical 45-46% levels; management indicates structural capability to operate at current margins and restore 2% margin by reducing new initiative spend if needed. Net margins down 3-4% with ~2% representing temporary investment phase. No specific timeline provided for margin recovery.
Key Targets:
The Q&A session revealed significant analyst concern about margin compression and volume volatility, with multiple participants probing the sustainability of current gross margins and the path to recovery. Analysts focused heavily on understanding the March volume decline (25% below normal), with management attributing this to broader client/industry weakness rather than company-specific issues. The employee expense growth trajectory generated substantial discussion, with management defending investments in new initiatives (~₹2-2.5 crore annually) while acknowledging core business headcount should grow slower than revenue. Multiple analysts sought quantification of free vs. paid calls and conversion metrics, which management largely deflected citing complexity. The pricing/discount strategy drew scrutiny given historical competitive positioning, with management emphasizing voluntary aggression to gain market share rather than defensive discounting. AI's potential impact was raised, with management expressing confidence that primary research remains insulated. Several analysts sought forward guidance, which management firmly declined to provide even at quarterly level, citing excessive variables (war, AI, client timing). The Huxsa business model (repeatability, economics, scale timeline) generated interest but management acknowledged sample size too small for meaningful disclosure. Overall, analysts appeared skeptical about near-term outlook and margin trajectory, while management maintained long-term confidence but showed unusual transparency about near-term uncertainty and investment trade-offs.